China Issues Guidelines for Informatization of Compact County-level Medical Communities
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and National Disease Control...
CDE Releases 91st Batch of Reference Preparations for Generic Drug Evaluation
China’s Center for Drug Evaluation (CDE) has released the 91st batch of reference preparations for...
China’s NHSA Issues Guidelines for Neurological Medical Services Pricing
China’s National Healthcare Security Administration (NHSA) has released the “Guidelines for the Pricing Project Initiation...
Grand Pharmaceutical Group Reports Strong 2024 Financials with 12.8% Revenue Growth
China-based Grand Pharmaceutical Group Co., Ltd. (HKG: 0512) revealed its 2024 financial performance, recording revenues...
Ping An Healthcare Reports 2024 Financial Turnaround with Growth in Healthcare Services
China-based Ping An Healthcare and Technology Co., Ltd (HKG: 1833), also known as Ping An...
Jiuzhitang’s Stem Cell Therapy for Autism Receives NMPA Clinical Trial Approval
China-based Jiuzhitang Co. Ltd (SHE: 000989) announced receiving clinical trial approval from the National Medical...
Newdel Biotech Secures A+ Round Funding to Accelerate DEL+AI-Driven Drug Discovery
Newdel Biotech recently announced the completion of an A+ round strategic investment led by XtalPi...
Sun-Novo Partners with Youjia Biomedical to Develop Antibody-Oligonucleotide Conjugate for Metabolic Diseases
China-based Beijing Sun-Novo Pharmaceutical Research Co., Ltd (SHA: 688621) has formed a partnership with compatriot...
Merck Sharp & Dohme Expands Durham Facility with $1B Investment for Vaccine Production
US-based giant Merck, Sharp & Dohme Inc. (MSD, NYSE: MRK) announced the opening of a...
Novartis’ Cosentyx Approved by NMPA for Moderate to Severe Hidradenitis Suppurativa
Swiss giant Novartis’ (NYSE: NVS) Cosentyx (secukinumab) has secured another indication approval from China’s National...
Legend Biotech Reports Strong Q4 and Full Year 2024 Financial Results
China-based Legend Biotech Corporation (NASDAQ: LEGN) released its Q4 and full-year 2024 financial results, highlighting...
Ono Pharmaceutical Licenses Ionis’ Sapablursen for Global Development in Polycythemia Vera
Japan-based Ono Pharmaceutical Co., Ltd. (TYO: 4528) announced an agreement with Ionis Pharmaceuticals, Inc. to...
Boehringer Ingelheim Launches One Medicine Platform with Veeva’s Development Cloud
German pharmaceutical giant Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) announced the successful launch of...
Biogen Initiates TRANSCEND Study for Felzartamab in Late AMR Kidney Transplant Patients
US-based Biogen Inc. (NASDAQ: BIIB) announced the initiation of the TRANSCEND study, a global Phase...
MindRank Ltd Receives FDA Clearance for MRANK-106 Clinical Study in Solid Tumors
China-based artificial intelligence (AI)-enabled drug developer MindRank Ltd announced receiving clearance from the US Food...
AIM Vaccine Co. Ltd Announces Market Filing for Innovative Serum-Free Rabies Vaccine
China-based AIM Vaccine Co., Ltd (HKG: 6660) announced plans to file for market approval for...
TowardPi Medical Secures RMB500 Million in Series E Round for Ophthalmic Equipment Expansion
China-based TowardPi (Beijing) Medical Technology Ltd, a leading ophthalmology equipment R&D company, has reportedly secured...
WuXi XDC and AbTis Partner to Advance Antibody-Drug Conjugate Innovation
WuXi XDC (HKG: 2268), a joint venture between Wuxi Biologics (HKG: 2269) and WuXi STA...
Ascletis Pharma’s ASC47 Shows Positive Results in Phase Ib Study for Weight Loss
China-based Ascletis Pharma Inc. (HKG: 1672) announced positive topline results from a Phase Ib clinical...
AstraZeneca’s Imfinzi Approved by NMPA for Early-Stage NSCLC Treatment
UK-based giant AstraZeneca (NASDAQ: AZN) received approval from China’s National Medical Products Administration (NMPA) for...